Osteoarticular well-being
Osteoarticular pathologies affect about 10% of the global population. Among these, the most frequent are rheumatic disorders and osteoarthritis which today represent two of the main causes of disability, moderate or severe, which are estimated to affect at least 40 million people in Europe alone.
In the osteoarticular field, River Pharma offers various complementary therapeutic solutions, which are administered orally or intra-articularly. The basis of the effectiveness of these products is High Molecular Weight Hyaluronic Acid of biofermentative origin, guaranteeing its purity. Its function is to stimulate the production of new cartilage, enhancing the repair processes of bone tissue.